Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Biomarkers in Brain Disease

Biomarkers in Brain Disease

Monday, January 26, 2009 - Wednesday, January 28, 2009

Oxford University Saïd Business School

Presented By

Presented by The New York Academy of Sciences and The Global Medical Excellence Cluster of South East England


Advances in biomarker development are revolutionizing the way we study, diagnose, and treat disease. However, progress in the development and use of biomarkers for diseases of the central nervous system has been limited by a number of difficulties - including inherent barriers associated with studying the brain.

Development of reliable biomarkers for brain disorders would dramatically accelerate research on the etiology, pathophysiology, disease progression, and therapeutic development of many very prevalent and devastating diseases including Alzheimer's, Parkinson's, multiple sclerosis, and others.

During this two-day meeting, international experts will gather to discuss the latest advances in biomarker technologies and biomarker development for brain disorders, as well as the logistical, regulatory, and funding challenges experienced by scientists working on clinical trials for biomarkers.

Scientific Organizing Committee:

  • Sabine Bahn, Cambridge University, UK
  • Karima Boubekeur, Roche, Switzerland
  • Maria Carrillo, Alzheimer's Association, USA
  • David Hawkes, University College, London
  • Andrew Lockhart, GlaxoSmithKline, UK
  • Simon Lovestone, Kings College, London
  • Richard Mayeux, Columbia, New York
  • Jeremy Nicholson, Imperial College, London
  • Ian Pike, Proteome Sciences, UK
  • Bill Potter, Merck, USA
  • Barbara Sahakian, University of Cambridge, UK
  • Gordon Wilcock, University of Oxford, UK 
  • Kathy Granger, The New York Academy of Sciences, USA


Silver sponsors

Merck Serono S.A. Geneva

Bronze sponsors

  • Imperial College
  • Johnson & Johnson
  • King's College, London
  • Oxford University
  • The Ellison Medical Foundation
  • University College, London
  • Wellcome Trust


Academy Friends

  • Alzheimer's Association
  • Eisai
  • Foresight Programme, Government Office for Science
  • Rules-Based Medicine, Inc
  • Schering-Plough Research Institute
  • Scout Diagnostics
  • The Alzheimer's Research Trust


Media Partners